BEKAY vs CHTM
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEKAY is a Buy and CHTM is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BEKAY’s FA Score shows that 1 FA rating(s) are green whileCHTM’s FA Score has 1 green FA rating(s).
- BEKAY’s FA Score: 1 green, 4 red.
- CHTM’s FA Score: 1 green, 4 red.
Price Growth
BEKAY (@Metal Fabrication) experienced а 0.00% price change this week, while CHTM (@Metal Fabrication) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Metal Fabrication industry was -5.60%. For the same industry, the average monthly price growth was -0.41%, and the average quarterly price growth was -1.95%.
Reported Earning Dates
BEKAY is expected to report earnings on Nov 22, 2024.
Industries' Descriptions
@Metal Fabrication (-5.60% weekly)The industry is involved in value-added processes including creation of metal structures like machines and parts by cutting, bending and assembling, using various raw materials. A fabrication shop often bids on a project/job, and then builds the product if awarded the contract. Robotics and automation are making their way into the industry apparently to fill in skills gap[s19] . RBC Bearings Incorporated, Timken Company and Valmont Industries, Inc. are some of the largest metal fabrication companies in the U.S.
| BEKAY | CHTM | BEKAY / CHTM | |
| Capitalization | 1.81B | N/A | - |
| EBITDA | 296M | N/A | - |
| Gain YTD | -12.107 | 0.149 | -8,152% |
| P/E Ratio | 8.06 | N/A | - |
| Revenue | 4.07B | N/A | - |
| Total Cash | 488M | N/A | - |
| Total Debt | 900M | N/A | - |
BEKAY | CHTM | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 6 Undervalued | 12 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 77 | 100 | |
PRICE GROWTH RATING 1..100 | 75 | 56 | |
P/E GROWTH RATING 1..100 | 85 | 100 | |
SEASONALITY SCORE 1..100 | 30 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BEKAY's Valuation (6) in the null industry is in the same range as CHTM (12). This means that BEKAY’s stock grew similarly to CHTM’s over the last 12 months.
BEKAY's Profit vs Risk Rating (100) in the null industry is in the same range as CHTM (100). This means that BEKAY’s stock grew similarly to CHTM’s over the last 12 months.
BEKAY's SMR Rating (77) in the null industry is in the same range as CHTM (100). This means that BEKAY’s stock grew similarly to CHTM’s over the last 12 months.
CHTM's Price Growth Rating (56) in the null industry is in the same range as BEKAY (75). This means that CHTM’s stock grew similarly to BEKAY’s over the last 12 months.
BEKAY's P/E Growth Rating (85) in the null industry is in the same range as CHTM (100). This means that BEKAY’s stock grew similarly to CHTM’s over the last 12 months.
| RSI ODDS (%) |
| Stochastic ODDS (%) |
| Momentum ODDS (%) |
| MACD ODDS (%) |
| TrendWeek ODDS (%) |
| TrendMonth ODDS (%) |
| Advances ODDS (%) |
| Declines ODDS (%) |
| BollingerBands ODDS (%) |
| Aroon ODDS (%) |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| EMQAX | 7.89 | -0.02 | -0.25% |
| Ashmore Emerging Markets Active Eq A | |||
| GABAX | 53.71 | -0.29 | -0.54% |
| Gabelli Asset AAA | |||
| PDEAX | 16.71 | -0.17 | -1.01% |
| PGIM Jennison Emerging Markets Eq Opps A | |||
| MAPLX | 22.32 | -0.23 | -1.02% |
| Morgan Stanley Inst Advantage L | |||
| FDCAX | 49.66 | -0.84 | -1.66% |
| Fidelity Capital Appreciation | |||
BEKAY and
Correlation & Price change
A.I.dvisor tells us that BEKAY and ESAB have been poorly correlated (+3% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BEKAY and ESAB's prices will move in lockstep.
| Ticker / NAME | Correlation To BEKAY | 1D Price Change % | ||
|---|---|---|---|---|
| BEKAY | 100% | N/A | ||
| ESAB - BEKAY | 3% Poorly correlated | -1.84% | ||
| RMTO - BEKAY | 2% Poorly correlated | N/A | ||
| MTRT - BEKAY | 1% Poorly correlated | N/A | ||
| CHTM - BEKAY | -0% Poorly correlated | N/A | ||
| GFLT - BEKAY | -0% Poorly correlated | N/A | ||
More | ||||
CHTM and
Correlation & Price change
A.I.dvisor tells us that CHTM and MTRT have been poorly correlated (+3% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHTM and MTRT's prices will move in lockstep.
| Ticker / NAME | Correlation To CHTM | 1D Price Change % | ||
|---|---|---|---|---|
| CHTM | 100% | N/A | ||
| MTRT - CHTM | 3% Poorly correlated | N/A | ||
| GFLT - CHTM | -0% Poorly correlated | N/A | ||
| BEKAY - CHTM | -0% Poorly correlated | N/A | ||
| ESAB - CHTM | -1% Poorly correlated | -1.84% | ||
| RMTO - CHTM | -1% Poorly correlated | N/A | ||
More | ||||